Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genotyping and refractory risk factors of mycoplasma pneumoniae pneumonia in Suzhou, China

18 Apr 2025

Abstract excerpt

OBJECTIVE: To investigate the genotyping and drug resistance of Mycoplasma pneumoniae (MP) epidemic strains in children and analyze the risk factors for refractory Mycoplasma pneumoniae pneumonia (RMPP). METHOD: Nasopharyngeal aspirates (NPA) were collected from hospitalized children with MP infection from September to October 2023. Tracheoscopy was performed when necessary, and Bronchoalveolar Lavage Fluid...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Microbial infections and disease research
Share to Pneumonia and Respiratory Infections
Share to Respiratory viral infections research

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 40251512
DOI: 10.1186/s12879-025-10964-w

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genotyping and refractory risk factors of mycoplasma pneumoniae pneumonia in Suzhou, ChinaPMID 40251512Read ↗

Macrolide resistance and risk factors for refractory Mycoplasma pneumoniae pneumonia in pediatric patients from Wuhu, China: A retrospective cohort study.Semantic proximity Read ↗

Molecular epidemiology of Mycoplasma pneumoniae pneumonia in children, Wuhan, 2020–2022Semantic proximity Read ↗

Molecular epidemiology of Mycoplasma pneumoniae pneumonia in children, Wuhan, 2020-2022Semantic proximity Read ↗

Clinical Characteristics and Disease Severity Analysis of Mycoplasma pneumoniae Pneumonia in Guangxi ChildrenCarrying Drug-Resistant Genes: A Retrospective Clinical StudySemantic proximity Read ↗

Prediction Model for Severe Mycoplasma pneumoniae Pneumonia: Treatment Guidance for Pediatric A2063/2064G-mutated InfectionsSemantic proximity Read ↗

Comparative analysis of clinical characteristics of drug-resistant Mycoplasma pneumoniae pneumonia and viral pneumonia in children under 6 years of ageSemantic proximity Read ↗

Increased in vitro antimicrobial resistance of Mycoplasma pneumoniae isolates obtained from children in Beijing, China, in 2023.Semantic proximity Read ↗

Correlation Analysis of DNA Load, Drug-resistant Mutations and Clinical Manifestation of Mycoplasma pneumoniae Infection in ChildrenSemantic proximity Read ↗

Association analysis of Mycoplasma pneumoniae 23S rRNA gene mutation with refractory Mycoplasma pneumoniae pneumonia in children.Semantic proximity Read ↗

Predominance of A2063G mutant strains in the Mycoplasma pneumoniae epidemic in children: A clinical and epidemiological study in 2023 in Wuhan, China.Semantic proximity Read ↗

Epidemiology and high-level macrolide resistance of Mycoplasma pneumoniae among children in Hangzhou, China: a 2024–2025 single-center surveillance studySemantic proximity Read ↗

Genomic epidemiology and antimicrobial susceptibility of clinical Mycoplasma pneumoniae isolates in Shanghai, 2023-2024.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.